Skip to main content

Assessed listed medicines evidence guidelines

Australian regulatory guidelines, version 1.2, April 2024

This guidance applies to assessed listed medicines that are eligible for evaluation by our Complementary and Over-the-counter Medicines Branch. 

Last updated

Help us improve the Therapeutic Goods Administration site